You are here

AusPAR: Budesonide / Eformoterol

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

29 April 2013
AusPAR Details
AusPAR
Active Ingredient
Budesonide / Eformoterol
Product Name
Symbicort Rapihaler
Sponsor
AstraZeneca Pty Ltd
Submission Number
PM-2008-03789-3-5
Submission Type
New strengths, Extension of indications, New dosing range, Other quality changes
Decision
Approved
AusPAR Date
26 February 2013
Publication Date

29 April 2013